These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 17186680

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 4. Hypertension and the kidney.
    Wiederkehr M, Toto R, Fenves AZ, Ram CV.
    Semin Nephrol; 2005 Jul; 25(4):236-45. PubMed ID: 16202696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [New concept of chronic kidney disease and blockade of renin-angiotensin system].
    Takeda T, Gejyo F.
    Nihon Rinsho; 2007 Sep; 65(9):1727-33. PubMed ID: 17877002
    [Abstract] [Full Text] [Related]

  • 9. The role of sympathetic nervous activity in renal injury and end-stage renal disease.
    Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP.
    Hypertens Res; 2010 Jun; 33(6):521-8. PubMed ID: 20339374
    [Abstract] [Full Text] [Related]

  • 10. Diabetic nephropathy.
    Ritz E.
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [Abstract] [Full Text] [Related]

  • 11. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
    Weir MR.
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):100S-105S. PubMed ID: 15837552
    [Abstract] [Full Text] [Related]

  • 12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protecting renal function in the hypertensive patient: clinical guidelines.
    Bakris GL.
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):112S-119S. PubMed ID: 15837554
    [Abstract] [Full Text] [Related]

  • 16. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [Abstract] [Full Text] [Related]

  • 19. [Hypertension and renal disease].
    Kamper AL, Pedersen EB, Strandgaard S.
    Ugeskr Laeger; 2009 Jun 15; 171(25):2109-13. PubMed ID: 19671393
    [Abstract] [Full Text] [Related]

  • 20. Chronic kidney disease has a more powerful impact on peripheral arterial disease than metabolic syndrome in Japanese type 2 diabetic patients.
    Tsunoda K, Shimajiri Y, Morita S, Furuta M, Kadoya Y, Yamada S, Nanjo K, Sanke T.
    Metab Syndr Relat Disord; 2009 Aug 15; 7(4):323-6. PubMed ID: 19558271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.